← All indications
Nausea
An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.
Subtype terms (1)
More specific conditions that are subtypes of Nausea in the MeSH hierarchy.
- Postoperative Nausea and Vomiting
129 drugs (105 approved, 24 experimental)
Drugs by status
Approved for this indication (27)
- bismuth subsalicylate
- nabilone
- chlorpromazine
- cinnarizine
- diphenhydramine
- granisetron
- ramosetron
- palonosetron
- levomepromazine
- dronabinol
- meclizine
- prochlorperazine
- tetrahydrocannabinol
- trimethobenzamide
- tropisetron
- ondansetron
- banhasasim-tang
- alizapride
- benzquinamide
- cyclopropylmethylscopolamine
- hydroxymagnesium aluminate
- rolapitant
- thiethylperazine
- aprepitant
- fosnetupitant
- wu-chu-yu tang
- goreisan
Phase 4 trials (47)
- hydrocodone
- propofol
- urea
- norepinephrine
- ketamine
- tadalafil
- esmolol
- oxycodone
- ibuprofen
- dimenhydrinate
- folic acid
- gabapentin
- isoflurane
- sevoflurane
- glycopyrronium
- haloperidol
- ketorolac
- metoclopramide
- acetaminophen
- lidocaine
- scopolamine
- rocuronium
- levobupivacaine
- celecoxib
- desflurane
- bupivacaine
- pantoprazole
- clonidine
- hydromorphone
- atropine
- +17 more
Phase 3 trials (16)
Phase 2 trials (30)
- ringer's lactate
- sumatriptan
- anisodamine
- irinotecan
- capsaicin
- cannabidiol
- essential oils
- fluorouracil
- paclitaxel
- lorazepam
- ephedrine
- leucovorin
- octreotide
- persumac
- lactose
- ropivacaine
- carboplatin
- Isatuximab
- cannabis
- beractant
- tramadol
- Acotiamide
- albuterol
- oxaliplatin
- mirtazapine
- pregabalin
- human rotavirus, live attenuated
- hesperidin
- ly3537021
- hrs5580
Phase 1 trials (11)
Other trials (26)
- phenylephrine
- vitamin d3
- dexrazoxane
- cyproheptadine
- dolasetron
- gemcitabine
- lactulose
- famotidine
- Iberis amara
- vitamin c
- vincristine
- ifosfamide
- proparacaine
- capecitabine
- menthol
- lactobacillus plantarum
- betahistine mesilate
- mesna
- almond
- pepsin
- lactobacillus bulgaricus
- naloxone
- phosphate
- gum
- lactobacillus casei
- vanilla essential oil
Organizations
Organization Involved with Phase 4 Indications (97)
- Eisai
- ProStraken
- Bausch Health Companies
- Roche
- Ipsen
- Allergan
- Duchesnay Inc.
- INC Research
- Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
- LG
- PETHEMA Foundation
- United States Army
- Adnan Menderes University
- Rockefeller University
- University of Pittsburgh
- Ain Shams University
- Albany Medical College
- Algemeen Ziekenhuis Maria Middelares
- Azienda Ospedaliera San Gerardo di Monza
- Cornell University
- Coastal Anesthesiology Consultants
- Harvard University
- Duke University
- D'Annunzio University of Chieti–Pescara
- Gachon University
- Government Medical College, Haldwani
- Henry Ford Health System
- Hospital Federal de Bonsucesso
- Instituto do Cancer do Estado de São Paulo
- Kyung Hee University
- +67 more
Organization Involved with Phase 3 Indications (87)
- Acacia Pharma Ltd
- Astellas
- AstraZeneca
- Helsinn
- Charleston Laboratories, Inc
- GW Pharmaceuticals Ltd.
- Heron Therapeutics
- Korea United Pharm. Inc.
- Oncotech
- Parexel
- Solvay
- Bionorica
- Otsuka
- Solasia Pharma K.K.
- National Cancer Institute (NCI)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- United States Navy
- Huazhong University of Science and Technology
- Medical University of Graz
- Arbeitsgemeinschaft medikamentoese Tumortherapie
- Baylor University
- Cairo University
- CM Chungmu Hospital
- Gazi University
- Harbin Medical University
- Hôpital Privé de Parly II - Le Chesnay
- Indiana University
- Inje University
- Instituto Mexicano del Seguro Social
- Istituto Nazionale per lo Studio e la Cura dei Tumori
- +57 more
Organization Involved with Phase 2 Indications (55)
- Takeda
- Schering-Plough
- Hangzhou Jiuyuan Gene Engineering Co. Ltd.,
- Rafa Laboratories
- SymBio Pharmaceuticals
- Teva
- Accenture
- Swiss National Science Foundation
- Fondazione Giovanni Pascale
- National Center for Complementary and Integrative Health (NCCIH)
- London Vaccination Clinic
- Sunnybrook Health Sciences Centre
- Associazione Salentina Angela Serra
- Blokhin's Russian Cancer Research Center
- Dartmouth University
- Faculdade de Medicina do ABC
- Emory University
- Gruppo Italiano Studio Linfomi
- King Fahd General Hospital
- Mashhad University of Medical Sciences
- New Mexico Cancer Care Alliance
- Northside Hospital, Inc.
- Northwestern University
- Oregon Health and Science University
- University of The West Indies
- University of Kansas
- University of Michigan
- University of South Florida
- University of Southern Denmark
- Wake Forest University
- +25 more
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (57)
- Roxane Laboratories
- National Research Institute of Tuberculosis and Lung Disease, Iran
- Shahid Beheshti University of Medical Sciences
- Chung-Ang University Hospital
- Barbara Ann Karmanos Cancer Institute
- University of Pennsylvania
- Benazir Bhutto Hospital, Rawalpindi
- Drexel University
- Faculdade de Ciências Médicas da Santa Casa de São Paulo
- University of Washington
- Gynecologic Oncology Group
- King Khaled Eye Specialist Hospital
- Korea Institute of Oriental Medicine
- Main Line Health
- Makassed General Hospital
- National University of Malaysia
- NHS Fife
- NRG Oncology
- Ochsner Health System
- Silesian University of Medicine
- Sichuan University
- The Hong Kong Polytechnic University
- Thomas Jefferson University
- University of Nebraska
- University of South Carolina
- University of Southern California
- University of Bern
- Virginia Commonwealth University
- Wayne State University
- Daegu Catholic University
- +27 more